Thank you, Bob, and good afternoon, everyone. Thank you for joining the call today. In my discussions of our second quarter fiscal year 2026 financial results, references to revenue, net income and net cash generated from operations are on a U.S. GAAP basis, while adjusted net income, adjusted earnings per share, adjusted EBITDA and free cash flow are on a non-GAAP basis. Reconciliations of our U.S. GAAP to non-GAAP measures are included in the tables attached to our earnings press release. Turning to our results. Our second quarter results are once again among the strongest in our history with record revenue and EPS. Second quarter revenue was $164.2 million, an increase of 16.7% from $140.7 million in the prior year quarter, marking our fourth consecutive quarter of double-digit top line growth. Revenue growth was driven predominantly by growth in our high-margin HealthTech vertical of 35.1%, travel, transportation and logistics of 20.2% and retail and e-commerce of 17.2% as well as strong performance by our digital acquisition services, partially offset by an expected decline in telecommunications, one of our smallest verticals of 23.1%. We continue to win and grow in all geographic markets and our focused efforts to grow our higher-margin offshore delivery locations are continuing to have a favorable impact on bottom line results. Our highest margin offshore revenues grew 16.2% compared to the prior year quarter. Our nearshore locations grew 8.5% and our onshore region grew 27.5%, driven by growth in our high-margin digital acquisition services. Offshore revenues comprised 52.3% of total revenue and onshore revenues expanded to 24% of total revenue from 22% in the prior year quarter, reflective of the growth in our digital acquisition services. Our higher-margin digital and omnichannel services continues to strengthen, growing 19% versus the prior year quarter to 82% of our total revenue. We have structurally built IBEX so our growth vectors are our highest margin regions in services, and we expect that we will continue to be successful in driving growth in these higher-margin regions in services as new client wins and growth in our embedded base continue to be focused in these areas. Second quarter net income increased to $12.2 million compared to $9.3 million in the prior year quarter. The increase was primarily driven by the continued growth of work in our higher-margin offshore regions and operating leverage gained from SG&A expenses as they decreased from 18.3% to 16.8% of revenue. Our tax rate was 19.1% versus 20.2% in the prior year quarter, primarily attributable to changes in revenue mix across our taxable jurisdictions and favorable discrete tax benefits in the current year quarter. We expect our effective tax rate before discrete items to remain consistent at 20% to 22% for the remaining quarters before any discrete items, including discrete tax benefits related to stock-based compensation. Fully diluted EPS was $0.83, up 45% from $0.57 in the prior year quarter. Contributing to the EPS growth was the impact from strong operating performance and fewer diluted shares outstanding as a result of our ongoing share repurchase program. Our weighted average diluted shares outstanding for the quarter were 14.7 million versus 16.5 million 1 year ago. Moving to non-GAAP measures. Adjusted EBITDA increased to a record of $20.7 million or 12.6% of revenue from $16.5 million or 11.8% of revenue for the same period last year. The 80 basis point improvement in adjusted EBITDA margin was primarily driven by growth in our higher-margin offshore locations during recent years, growth in key high-margin verticals from existing and new clients launched throughout fiscal year 2025 and fiscal year 2026 to date and a reduction in SG&A expenses as a percentage of revenue. Adjusted net income increased to $12.8 million from $9.6 million in the prior year quarter. Non-GAAP fully diluted earnings per share increased 46% to $0.87 from $0.59 in the prior year quarter. As a company, we're pleased with the client diversification we have established over the last several years. For the second quarter of fiscal year 2026, our largest client accounted for 10% of revenue, and our top 5, top 10 and top 25 client concentrations represented 39%, 57% and 79% of overall revenue, respectively, as compared to 39%, 54% and 79% of overall revenue in the prior year quarter, representative of a well-diversified client portfolio. Over the past decade, we have done a tremendous job retaining our top 25 clients and are excited to see one of our signature wins from fiscal year '25 already move in the top 20 and one of our signature client wins from fiscal year '24 move into the top 10. Switching to our verticals. HealthTech increased to 17.4% of second quarter revenue versus 15.1% in the prior year quarter. Travel, transportation and logistics increased to 14.1% versus 13.7% in the prior year quarter. Retail and e-commerce remained consistent at 28.6%, and our other vertical increased to 13.7% compared to 10.6% in the prior year quarter. These increases were driven by continued growth in multiple offshore geographies and our continued ability to win significant new clients in these verticals. Conversely, our exposure to the telecommunications vertical decreased to 8.7% of revenue for the quarter versus 13.1% in the prior year quarter as we see lower volumes from legacy carriers, marking the first time since pre-IPO, this vertical comprises less than 10% of revenue. Revenues from the FinTech vertical were relatively flat and represented 9.3% of revenue for the quarter versus 11% in the prior year with expectation of growth in the ensuing quarters. Moving to cash flow. Net cash generated from operating activities was a second quarter record of $6.6 million for the second quarter of fiscal year 2026 compared to $1.1 million for the prior year quarter. The increase was driven by increased revenues and profitability as well as lower use of working capital. Our DSOs were 73 days, up from 71 days at the end of the first quarter, which is consistent with our expectations. We expect our DSOs to remain stable in the mid-70s on a go-forward basis. Capital expenditures were $11.7 million or 7.1% of revenue for the second quarter of fiscal year 2026 versus $4.3 million or 3.1% of revenue in the prior year quarter. This planned increase was primarily driven by expansion in our offshore regions to meet our strong demand. Following our typical seasonal pattern, free cash flow was an outflow of $5.1 million in the current quarter compared to an outflow of $3.2 million in the prior year quarter due to the increase in capital expenditures. During the quarter, we repurchased approximately 78,000 shares for $2.9 million, bringing our fiscal year share repurchase to $170,000 or $5.6 million and leaving $7.8 million on our share repurchase authorization. We ended the second quarter with $15.5 million of cash and debt of $1.4 million for a net cash position of $14 million, consistent with a net cash position of $13.7 million at the end of our last fiscal year. In the second quarter, we continued to build on the momentum we have generated over the past 12 months. Our strong quarterly revenue performance was again led by meaningful growth in our higher-margin geographies, services and vertical markets, particularly in HealthTech. This combination of drivers led to a record quarterly adjusted EBITDA of $20.7 million. As we look ahead to the second half of the fiscal year, our robust balance sheet is enabling us to make opportunistic investments to further extend our current AI leadership position. Additionally, with the clear returns we've already seen, we are proactively investing in increased sales resources as well as capacity in our top-performing geographies, positioning us for further success in the years ahead. Considering our outperformance in fiscal year 2026 thus far, we are confident in further raising our revenue and adjusted EBITDA guidance for the year. Revenue is now expected to be in the range of $620 million to $630 million versus a previous range of $605 million to $620 million. Adjusted EBITDA is now expected to be in the range of $80 million to $82 million versus a previous range of $78 million to $81 million. We now expect capital expenditures to be at the upper end of our previous $20 million to $25 million range. Our business is well positioned for today and the years ahead, and we're excited about the future of IBEX as we head into the third quarter of fiscal year 2026 and beyond. With that, Bob and I will now take questions. Operator, please open the line.